Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators intend to select patients with resectable NSCLC treated with
immuno-neoadjuvant therapy in combination with chemotherapy, and systematically observe the
effect of preoperative anti-PD-1 monotherapy on patients' perioperative pain and opioid
analgesia, and evaluate its effect on the incidence and severity of patients' postoperative
delirium, in order to provide a clinical basis for the perioperative management of patients
treated with immuno-neoadjuvant therapy and promote their postoperative recovery.
Phase:
N/A
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Collaborators:
Tianjin Chest Hospital Tianjin Medical University General Hospital